2006 Annual Meeting | New Perspectives on ALS Treatment
| 06:45 AM - 07:15 AM | Treating Symptoms of ALS Robert G. Miller, MD | |
| 06:45 AM - 08:30 AM | Breakfast | |
| 07:15 AM - 07:45 AM | End-of-Life Issues: ALS Wendy Johnston, MD, FRCP(C), FAAN | |
| 07:45 AM - 08:15 AM | Clinical Trials Hiroshi Mitsumoto, MD, FAAN | |
| 08:15 AM - 08:30 AM | Questions and Answers | 
| Robert G. Miller, MD | The institution of Dr. Miller has received research support from Nurown. | 
| Wendy Johnston, MD, FRCP(C), FAAN | Dr. Johnston has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Johnston has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen Inc.. Dr. Johnston has a non-compensated relationship as a Board Member with ALS Canada that is relevant to AAN interests or activities. Dr. Johnston has a non-compensated relationship as a Chair with Canadian ALS Clinical Research Group that is relevant to AAN interests or activities. | 
| Hiroshi Mitsumoto, MD, FAAN | Dr. Mitsumoto has nothing to disclose. |